NewAmsterdam Pharma Company N.V.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2026 | $67.4M | $732.6M | $457.6M |
| Jun 2026 | $73.0M | $704.5M | $424.2M |
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2026 | $67.4M | $732.6M | $457.6M |
| Jun 2026 | $73.0M | $704.5M | $424.2M |